3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Brain Neoplasms
10
Carcinoma, Hepatocellular
9
Neoplasm Metastasis
7
Neoplasms
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Colorectal Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Prostatic Neoplasms
3
Melanoma
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Glioblastoma
2
Adenocarcinoma of Lung
2
Triple Negative Breast Neoplasms
1
Sarcoma
1
Recurrence
1
Radiotherapy
1
Prostate Cancer Metastatic
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Liver Neoplasms
1
Liver Diseases
1
Kidney Neoplasms
1
Glioma
1
Carcinoma, Transitional Cell
1
Carcinoma, Merkel Cell
1
Interventions
siremadlin
1
selinexor
1
posaconazole
1
midostaurin
1
fludarabine
1
durvalumab
1
blinatumomab
1
avelumab
1
Radiosurgery
1
Midazolam
1
Lenalidomide
1
Idarubicin
1
Dexamethasone
1
Daunorubicin
1
Cytarabine
1
Cyclophosphamide
1
Calcium Dobesilate
1
Azacitidine
1
Anthracyclines
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasm, Residual
×
Radiosurgery
×
Clear all
NCT04944173
2024-09-03
SCION
University of British Columbia
Phase 2
Withdrawn